Avidian Wealth Enterprises’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$278K Sell
5,775
-146
-2% -$6.81K 0.01% 555
2025
Q4
$287K Buy
5,921
+31
+0.5% +$1.54K 0.01% 483
2025
Q3
$278K Buy
5,890
+154
+3% +$7.43K 0.01% 484
2025
Q2
$277K Sell
5,736
-17
-0.3% -$869 0.01% 455
2025
Q1
$319K Buy
5,753
+43
+0.8% +$2.33K 0.01% 405
2024
Q4
$275K Sell
5,710
-30
-0.5% -$1.52K 0.01% 418
2024
Q3
$331K Sell
5,740
-127
-2% -$6.86K 0.02% 380
2024
Q2
$285K Sell
5,867
-3,189
-35% -$154K 0.01% 400
2024
Q1
$440K Sell
9,056
-184
-2% -$8.98K 0.02% 284
2023
Q4
$460K Buy
9,240
+330
+4% +$16.1K 0.03% 277
2023
Q3
$478K Sell
8,910
-349
-4% -$18.6K 0.03% 265
2023
Q2
$499K Buy
9,259
+450
+5% +$24.2K 0.03% 265
2023
Q1
$479K Hold
8,809
0.03% 302
2022
Q4
$427K Sell
8,809
-130
-1% -$5.71K 0.03% 299
2022
Q3
$340K Sell
8,939
-212
-2% -$9.45K 0.02% 301
2022
Q2
$458K Buy
9,151
+128
+1% +$6.79K 0.03% 279
2022
Q1
$463K Sell
9,023
-1,333
-13% -$68.8K 0.03% 314
2021
Q4
$519K Buy
10,356
+1,625
+19% +$80.4K 0.03% 291
2021
Q3
$421K Buy
8,731
+415
+5% +$21.1K 0.03% 240
2021
Q2
$438K Buy
8,316
+37
+0.4% +$1.93K 0.03% 245
2021
Q1
$409K Sell
8,279
-1,062
-11% -$51K 0.03% 240
2020
Q4
$454K Buy
9,341
+246
+3% +$12.1K 0.04% 199
2020
Q3
$456K Buy
9,095
+647
+8% +$33.3K 0.05% 169
2020
Q2
$431K Buy
8,448
+640
+8% +$31.1K 0.06% 148
2020
Q1
$341K Sell
7,808
-89
-1% -$4.26K 0.05% 134
2019
Q4
$396K Buy
7,897
+406
+5% +$19K 0.06% 144
2019
Q3
$347K Buy
7,491
+740
+11% +$31.9K 0.06% 134
2019
Q2
$292K Buy
6,751
+1,548
+30% +$65.8K 0.07% 109
2019
Q1
$230K Buy
+5,203
New +$223K 0.05% 113
2018
Q1
Sell
-1,372
Closed -$59K 111
2017
Q4
$59K Buy
+1,372
New +$63.3K 15.78% 1

Other funds holding SNY

Avidian Wealth Enterprises's SNY Position: Q1 2026 in Review

Avidian Wealth Enterprises reduced its Sanofi (SNY) stake by 2.5% in Q1 2026, selling an estimated $6.81K and leaving 5,775 shares worth $278K. The position accounts for 0.01% of the portfolio, ranked #555.

Avidian Wealth Enterprises first reported a position in SNY in Q4 2017 and has held it in 30 quarters since. The position peaked at $519K in Q4 2021. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Avidian Wealth Enterprises held 5,775 shares of Sanofi worth $278K as of Q1 2026.
  • Avidian Wealth Enterprises sold 146 Sanofi shares in Q1 2026, an estimated $6.81K.
  • Sanofi made up 0.01% of Avidian Wealth Enterprises's portfolio in Q1 2026, its #555 holding.
  • Avidian Wealth Enterprises first reported a position in Sanofi in Q4 2017 and has held it in 30 quarters since.
  • Avidian Wealth Enterprises's Sanofi position peaked at $519K in Q4 2021.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Avidian Wealth Enterprises's 13F filing for Q1 2026, filed 7 May 2026.